237 related articles for article (PubMed ID: 19795578)
1. Sentinel lymphadenectomy in breast cancer: an update on the NCCN clinical practice guidelines.
Anderson BO
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S64-70. PubMed ID: 19795578
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy as the new standard of care in the surgical treatment for breast cancer.
Ferrari A; Rovera F; Dionigi P; Limonta G; Marelli M; Besana Ciani I; Bianchi V; Vanoli C; Dionigi R
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1503-15. PubMed ID: 17069533
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy in the management of breast cancer.
Kumar R; Bozkurt MF; Zhuang H; Alavi A
Indian J Cancer; 2003; 40(2):60-6. PubMed ID: 14716120
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in sentinel lymph node biopsy for breast cancer.
Goyal A; Mansel RE
Curr Opin Oncol; 2008 Nov; 20(6):621-6. PubMed ID: 18841040
[TBL] [Abstract][Full Text] [Related]
5. [Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].
Kocjan G
Acta Med Croatica; 2008 Oct; 62(4):391-401. PubMed ID: 19205416
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy.
Menard JP; Extra JM; Jacquemier J; Buttarelli M; Lambaudie E; Bannier M; Brenot Rossi I; Houvenaeghel G
Eur J Surg Oncol; 2009 Sep; 35(9):916-20. PubMed ID: 19157769
[TBL] [Abstract][Full Text] [Related]
7. [Low invasion in sentinel lymph node according to the European Working Group In Breast Screening Pathology (EWGBSP) recommendations and non sentinel invasion risk in breast cancer].
Gauthier T; Fermeaux V; Mollard J; Aubard Y
Gynecol Obstet Fertil; 2009 Jun; 37(6):481-7. PubMed ID: 19457697
[TBL] [Abstract][Full Text] [Related]
8. Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy.
Boughey JC; Cormier JN; Xing Y; Hunt KK; Meric-Bernstam F; Babiera GV; Ross MI; Kuerer HM; Singletary SE; Bedrosian I
Cancer; 2007 Dec; 110(11):2542-50. PubMed ID: 17932905
[TBL] [Abstract][Full Text] [Related]
9. [Sentinel node detection applied to breast cancer: 2007 update].
Classe JM; Houvenaeghel G; Sagan C; Leveque J; Ferron G; Dravet F; Pioud R; Catala L; Rousseau C; Curtet C; Descamps P
J Gynecol Obstet Biol Reprod (Paris); 2007 Jun; 36(4):329-37. PubMed ID: 17400402
[TBL] [Abstract][Full Text] [Related]
10. The value of level III clearance in patients with axillary and sentinel node positive breast cancer.
Dillon MF; Advani V; Masterson C; O'Loughlin C; Quinn CM; O'Higgins N; Evoy D; McDermott EW
Ann Surg; 2009 May; 249(5):834-9. PubMed ID: 19387317
[TBL] [Abstract][Full Text] [Related]
11. Options and limits of surgery after pre-operative chemotherapy in breast cancer.
Thomas A; Ohlinger R; Hauschild M; Mustea A; Blohmer JU; Kümmel S
Anticancer Res; 2006; 26(2C):1677-82. PubMed ID: 16617561
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled clinical trial on sentinel node lymph node dissection versus axillary lymph node dissection: a matter of technique or patient selection?
Carmichael AR
Ann Surg; 2008 Nov; 248(5):895; author reply 895-6. PubMed ID: 18948821
[No Abstract] [Full Text] [Related]
13. Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer.
Takei H; Kurosumi M; Yoshida T; Ninomiya J; Ishikawa Y; Hayashi Y; Tozuka K; Asakawa H; Oba H; Inoue K; Tabei T
Breast; 2009 Aug; 18(4):244-7. PubMed ID: 19559610
[TBL] [Abstract][Full Text] [Related]
14. [The advantages of preoperative systemic therapy in breast cancer].
Mieog JS; van Nes JG; van de Velde CJ
Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2501-6. PubMed ID: 19055256
[TBL] [Abstract][Full Text] [Related]
15. [Quadrantectomy and removal of the sentinel lymph node under local anaesthesia in the day hospital setting].
Ranieri E; Larcinese A; Barberi S; Caprio G; Naticchioni E; Civitelli L; Paglicci C; Pagni P; Zancla S; Rengo M; Di Giorgio A
Chir Ital; 2008; 60(3):391-4. PubMed ID: 18709777
[TBL] [Abstract][Full Text] [Related]
16. NCCN breast cancer clinical practice guidelines in oncology: an update.
Carlson RW
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S61-3. PubMed ID: 19795577
[TBL] [Abstract][Full Text] [Related]
17. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
Buchholz TA; Lehman CD; Harris JR; Pockaj BA; Khouri N; Hylton NF; Miller MJ; Whelan T; Pierce LJ; Esserman LJ; Newman LA; Smith BL; Bear HD; Mamounas EP
J Clin Oncol; 2008 Feb; 26(5):791-7. PubMed ID: 18258988
[TBL] [Abstract][Full Text] [Related]
18. [Feasibility of the sentinel node biopsy in breast cancer in case of histological multifocality diagnosis].
Bézu C; Coutant C; Antoine M; Moutafoff C; Guillo E; Daraï E; Rouzier R; Uzan S
Gynecol Obstet Fertil; 2009; 37(7-8):604-10. PubMed ID: 19577499
[TBL] [Abstract][Full Text] [Related]
19. Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial).
Smith MJ; Gill PG; Wetzig N; Sourjina T; Gebski V; Ung O; Campbell I; Kollias J; Coskinas X; Macphee A; Young L; Simes RJ; Stockler MR;
Breast Cancer Res Treat; 2009 Sep; 117(1):99-109. PubMed ID: 18925434
[TBL] [Abstract][Full Text] [Related]
20. Axillary-conserving surgery is facilitated by neoadjuvant chemotherapy of breast cancer.
Beatty JD; Precht LM; Lowe K; Atwood M
Am J Surg; 2009 May; 197(5):637-41; discussion 641-2. PubMed ID: 19321159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
